Company / Working Capital per Share
Astria Therapeutics, Inc. Working Capital per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital per Share
$5.62
FY2024
5-year range
$5.62 / $14.95
FY2020-FY2024
Trend
-29.3%
vs FY2023
Sector context
#102 of 210
Health Care
What the data says
At $5.62, Astria Therapeutics, Inc.'s working capital per share ranks #102 of 210 in the Health Care sector. Working Capital per Share has fluctuated over the past 10 years, ranging from $1.92 in FY2016 to $14.95 in FY2022.
Based on SEC 10-K filings.
5.62 in FY2024 with a 5-year CAGR of +9.9%.
Declined from $14.95 to $5.62 over the past 2 years.
Health Care sector context is included.
Working Capital per Share over time
Growth rates
- 3-Year CAGR
- -25.6%
- 5-Year CAGR
- +9.9%
- 10-Year CAGR
- -
Sector benchmark
#102 of 210 in Health CareTop 49% of 210This company $5.62 Sector average $146.86
▼
-96.2% below sector average
Key checks
Key Insights
- In FY2024, working capital per share decreased 29.3% year-over-year.
- Ranks #102 out of 210 companies in the Health Care sector.
- Peak working capital per share was recorded in FY2022.
- Lowest working capital per share in the period was in FY2016.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 5.45 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working Capital per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $5.62 | -29.3% |
| FY2023 | $7.95 | -46.9% |
| FY2022 | $14.95 | +9.5% |
| FY2021 | $13.65 | +4.6% |
| FY2020 | $13.06 | +272.8% |
| FY2019 | $3.50 | -49.0% |
| FY2018 | $6.87 | +30.2% |
| FY2017 | $5.28 | +174.6% |
| FY2016 | $1.92 | -72.3% |
| FY2015 | $6.94 | -72.7% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026